F-STAR THERAPEUTICS, INC. Revenue
F-STAR THERAPEUTICS, INC. reported Revenue of $1.13 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Income Statement › Revenue
us-gaap:Revenues · last filed 2022-11-10
- F-STAR THERAPEUTICS, INC. revenues for the quarter ending 2022-09-30 was $1.13M, a 49.80% increase year-over-year.
- F-STAR THERAPEUTICS, INC. revenues for the quarter ending 2022-06-30 was $0.00.
- F-STAR THERAPEUTICS, INC. revenues for the quarter ending 2022-03-31 was $2.55M, a 12.55% decline year-over-year.
- F-STAR THERAPEUTICS, INC. revenues for the quarter ending 2021-12-31 was $17.50M, a 10635.58% increase year-over-year.
- F-STAR THERAPEUTICS, INC. revenues for fiscal 2021 was $21.17M, a 88.05% increase from fiscal 2020.
- F-STAR THERAPEUTICS, INC. revenues for fiscal 2020 was $11.26M, a 60.26% decline from fiscal 2019.
- F-STAR THERAPEUTICS, INC. revenues for fiscal 2019 was $28.32M.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2022-09-30 | $1.13M 10-Q · filed 2022-11-10 | $1.13M derived: sum of 2 quarters · filed 2022-11-10 | $3.68M 10-Q · filed 2022-11-10 | $21.18M derived: sum of 4 quarters · filed 2022-11-10 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-11 | $2.55M 10-Q · filed 2022-08-11 | $20.05M derived: sum of 3 quarters · filed 2022-08-11 | $20.80M derived: sum of 4 quarters · filed 2022-11-10 |
| 2022-03-31 | $2.55M 10-Q · filed 2022-05-10 | $20.05M derived: sum of 2 quarters · filed 2022-05-10 | $20.80M derived: sum of 3 quarters · filed 2022-11-10 | $20.80M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-12-31 | $17.50M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $18.25M derived: sum of 2 quarters · filed 2022-11-10 | $18.25M derived: sum of 3 quarters · filed 2022-11-10 | $21.17M 10-K · filed 2022-03-15 |
| 2021-09-30 | $751.00K 10-Q · filed 2022-11-10 | $751.00K derived: sum of 2 quarters · filed 2022-11-10 | $3.67M 10-Q · filed 2022-11-10 | $3.83M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-11 | $2.92M 10-Q · filed 2022-08-11 | $3.08M derived: sum of 3 quarters · filed 2022-08-11 | $12.28M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $2.92M 10-Q · filed 2022-05-10 | $3.08M derived: sum of 2 quarters · filed 2022-05-10 | $12.28M derived: sum of 3 quarters · filed 2022-05-10 | $12.82M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $163.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $9.36M derived: sum of 2 quarters · filed 2022-03-15 | $9.90M derived: sum of 3 quarters · filed 2022-03-15 | $11.26M 10-K · filed 2022-03-15 |
| 2020-09-30 | $9.20M 10-Q · filed 2021-11-10 | $9.74M derived: sum of 2 quarters · filed 2021-11-10 | $11.09M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $543.00K 10-Q · filed 2021-08-13 | $1.90M 10-Q · filed 2021-08-13 | ||
| 2020-03-31 | $1.35M 10-Q · filed 2021-05-17 | |||
| 2019-12-31 | $28.32M 10-K · filed 2021-03-30 |